CONMED PE Ratio 2012-2026 | CNMD
Current and historical p/e ratio for CONMED (CNMD) from 2012 to 2026. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. CONMED PE ratio as of September 16, 2026 is 9.82.
| CONMED PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-09-16 | 47.04 | 25.43 | |
| 2026-06-30 | 32.73 | $1.85 | 17.69 |
| 2026-03-31 | 35.36 | $1.77 | 19.98 |
| 2025-12-31 | 40.60 | $1.51 | 26.89 |
| 2025-09-30 | 47.03 | $2.06 | 22.83 |
| 2025-06-30 | 51.88 | $3.54 | 14.66 |
| 2025-03-31 | 59.94 | $3.81 | 15.73 |
| 2024-12-31 | 67.70 | $4.25 | 15.93 |
| 2024-09-30 | 70.94 | $4.21 | 16.85 |
| 2024-06-30 | 68.19 | $3.14 | 21.72 |
| 2024-03-31 | 78.56 | $2.61 | 30.10 |
| 2023-12-31 | 107.19 | $2.04 | 52.54 |
| 2023-09-30 | 98.54 | $2.01 | 49.02 |
| 2023-06-30 | 132.53 | $2.99 | 44.32 |
| 2023-03-31 | 101.14 | $-3.09 | 0.00 |
| 2022-12-31 | 86.12 | $-2.68 | 0.00 |
| 2022-09-30 | 77.73 | $-2.95 | 0.00 |
| 2022-06-30 | 92.65 | $-3.96 | 0.00 |
| 2022-03-31 | 143.42 | $2.10 | 68.30 |
| 2021-12-31 | 136.67 | $1.94 | 70.45 |
| 2021-09-30 | 125.95 | $2.04 | 61.74 |
| 2021-06-30 | 132.08 | $1.80 | 73.38 |
| 2021-03-31 | 125.33 | $0.43 | 291.46 |
| 2020-12-31 | 107.31 | $0.32 | 335.36 |
| 2020-09-30 | 75.23 | $-0.02 | 0.00 |
| 2020-06-30 | 68.69 | $-0.02 | 0.00 |
| 2020-03-31 | 54.49 | $1.13 | 48.22 |
| 2019-12-31 | 106.08 | $0.97 | 109.36 |
| 2019-09-30 | 91.04 | $1.00 | 91.04 |
| 2019-06-30 | 80.86 | $0.97 | 83.36 |
| 2019-03-31 | 78.42 | $1.08 | 72.61 |
| 2018-12-31 | 60.37 | $1.41 | 42.82 |
| 2018-09-30 | 74.28 | $2.52 | 29.47 |
| 2018-06-30 | 68.46 | $2.58 | 26.53 |
| 2018-03-31 | 59.07 | $2.50 | 23.63 |
| 2017-12-31 | 47.39 | $1.97 | 24.06 |
| 2017-09-30 | 48.59 | $0.56 | 86.77 |
| 2017-06-30 | 46.99 | $0.56 | 83.91 |
| 2017-03-31 | 40.81 | $0.44 | 92.75 |
| 2016-12-31 | 40.39 | $0.52 | 77.67 |
| 2016-09-30 | 36.47 | $0.55 | 66.31 |
| 2016-06-30 | 43.24 | $0.61 | 70.88 |
| 2016-03-31 | 37.82 | $0.78 | 48.48 |
| 2015-12-31 | 39.52 | $1.09 | 36.26 |
| 2015-09-30 | 42.63 | $1.23 | 34.66 |
| 2015-06-30 | 51.83 | $0.98 | 52.89 |
| 2015-03-31 | 44.75 | $1.08 | 41.43 |
| 2014-12-31 | 39.69 | $1.16 | 34.22 |
| 2014-09-30 | 32.37 | $1.12 | 28.91 |
| 2014-06-30 | 38.60 | $1.25 | 30.88 |
| 2014-03-31 | 37.82 | $1.22 | 31.00 |
| 2013-12-31 | 36.83 | $1.28 | 28.77 |
| 2013-09-30 | 29.28 | $1.29 | 22.70 |
| 2013-06-30 | 26.81 | $1.41 | 19.02 |
| 2013-03-31 | 29.10 | $1.43 | 20.35 |
| 2012-12-31 | 23.76 | $1.41 | 16.85 |
| 2012-09-30 | 24.10 | $0.16 | 150.63 |
| 2012-06-30 | 23.27 | $0.13 | 179.02 |
| 2012-03-31 | 24.98 | $0.07 | 356.89 |
| 2011-12-31 | 21.36 | $0.03 | 711.98 |
| 2011-09-30 | 19.15 | $1.14 | 16.79 |
| 2011-06-30 | 23.70 | $1.16 | 20.43 |
| 2011-03-31 | 21.87 | $1.11 | 19.70 |
| 2010-12-31 | 21.99 | $1.05 | 20.94 |
| 2010-09-30 | 18.65 | $0.99 | 18.84 |
| 2010-06-30 | 15.50 | $0.72 | 21.53 |
| 2010-03-31 | 19.81 | $0.52 | 38.10 |
| 2009-12-31 | 18.97 | $0.42 | 45.17 |
| 2009-09-30 | 15.95 | $0.53 | 30.10 |
| 2009-06-30 | 12.91 | $0.82 | 15.75 |
| 2009-03-31 | 11.99 | $1.17 | 10.25 |
| 2008-12-31 | 19.92 | $1.37 | 14.54 |
| 2008-09-30 | 26.63 | $1.38 | 19.29 |
| 2008-06-30 | 22.09 | $1.34 | 16.49 |
| 2008-03-31 | 21.33 | $1.26 | 16.93 |
| 2007-12-31 | 19.23 | $1.33 | 14.46 |
| 2007-09-30 | 23.29 | $0.19 | 122.58 |
| 2007-06-30 | 24.36 | $0.02 | 1218.17 |
| 2007-03-31 | 24.32 | $-0.18 | 0.00 |
| 2006-12-31 | 19.24 | $-0.45 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $1.406B | $1.375B |
| CONMED Corporation is a major medical products manufacturer specializing in surgical instruments and devices for minimally invasive procedures and monitoring. A significant portion of the company's revenues are derived from products designed for the orthopedic surgery markets of arthroscopy and powered surgical instruments. The company also sells products for general and other surgical specialties such as electrosurgery systems for all types of surgery, and endosurgery instruments for minimally invasive laparoscopic surgery. Patient Care products, including ECG electrodes for heart monitoring and pulse oximetry for blood oxygenation monitoring, are provided for various clinical settings.The company operates in two revenue segments: Orthopedic Surgery and General Surgery. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $104.880B | 22.04 |
| Cardinal Health (CAH) | United States | $54.109B | 20.66 |
| Becton Dickinson (BDX) | United States | $51.228B | 14.30 |
| West Pharmaceutical Services (WST) | United States | $25.687B | 42.94 |
| Straumann Holding AG (SAUHY) | Switzerland | $18.592B | 0.00 |
| Align Technology (ALGN) | United States | $10.528B | 16.28 |
| Cooper (COO) | United States | $10.130B | 11.56 |
| Henry Schein (HSIC) | United States | $9.754B | 16.48 |
| Merit Medical Systems (MMSI) | United States | $5.146B | 23.48 |
| DENTSPLY SIRONA (XRAY) | United States | $1.960B | 6.87 |
| STAAR Surgical (STAA) | United States | $1.125B | 35.07 |
| Pro-Dex (PDEX) | United States | $0.214B | 19.97 |
| Lifevantage (LFVN) | United States | $0.077B | 11.04 |